Track topics on Twitter Track topics that are important to you
BlackThorn Therapeutics has promoted Bill Martin to president and chief operating officer. Martin had served as the San Francisco company’s chief scientific officer. He succeeds Greg Vontz as president. Vontz, who also held the role of CEO, has left the company. In other moves, BlackThorn appointed Paul Berns, a venture partner at ARCH Venture Partners, […]
Original Article: BlackThorn Names Bill Martin President & Chief Operating OfficerNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...